Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC)

Rajiv Gandhi Cancer Institute and Research Centre in Rohini North Delhi is India's most respected dedicated cancer hospital, a NABH and NABL accredited institution that has established itself over decades as the national benchmark for cancer surgical excellence, oncological research and comprehensive cancer care. Founded with the specific mission of providing specialist cancer treatment, RGCIRC combines the depth of focus achievable only in a dedicated cancer hospital with comprehensive medical, surgical and radiation oncology services under one roof. The Uro-Oncology department at RGCIRC, led by Dr. Sudhir Rawal who trained at MD Anderson Cancer Centre in Houston USA, is widely regarded as India's finest uro-oncological surgical programme. Dr. Rawal has performed over 7,000 uro-oncological surgeries and has introduced robotic radical prostatectomy, robotic radical cystectomy with neobladder reconstruction and robotic partial nephrectomy to RGCIRC, achieving outcomes that match or exceed published international benchmarks for cancer control, urinary continence and sexual function preservation. This programme attracts patients from across India and internationally for prostate, bladder and kidney cancer surgery. The Head and Neck Oncology programme at RGCIRC is one of India's most experienced, managing complex malignancies of the oral cavity, pharynx, larynx, thyroid and salivary glands with multidisciplinary surgical, medical and radiation oncology decision-making. The Breast Cancer Centre provides comprehensive breast cancer management including breast-conserving surgery, oncoplastic techniques, sentinel node biopsy, adjuvant chemotherapy and targeted therapy. The Bone Marrow Transplant unit at RGCIRC performs both autologous and allogeneic transplants within NABH-compliant HEPA-filtered BMT suites, supporting the haemato-oncology programme's management of acute leukaemias, lymphomas, myeloma and aplastic anaemia. RGCIRC's dedicated cancer hospital focus means every element of its infrastructure – operating theatres, ICUs, imaging, pathology, pharmacy – is optimised for oncological care. For patients with cancer seeking treatment at India's most specialised and experienced dedicated cancer hospital in Delhi NCR, RGCIRC offers unmatched surgical oncology expertise and comprehensive multidisciplinary cancer management. RGCIRC's status as India's most respected dedicated cancer hospital brings an important clinical advantage: every clinician, nurse, therapist and support staff member works exclusively with cancer patients, creating a depth of oncological expertise and specialised care culture that is difficult to replicate in a general hospital environment where cancer patients share resources and attention with other clinical populations. The hospital's pathology and molecular diagnostics laboratory is among India's most comprehensive for oncological testing, offering next-generation sequencing, immunohistochemistry, FISH, PCR-based mutation testing and liquid biopsy for circulating tumour DNA — the full range of molecular diagnostic tools required for precision oncology. Rapid turnaround times for complex molecular pathology reporting enable timely treatment decisions without the delays that can compromise outcome in aggressive malignancies. RGCIRC's palliative care and pain management programme is one of its most compassionate offerings, providing expert symptom management, psychological support and end-of-life care co-ordination for patients with advanced cancer who require relief from pain and suffering alongside or instead of curative treatment. This comprehensive palliative programme reflects RGCIRC's commitment to cancer care that addresses the whole patient — not just the disease — across every stage of the oncological journey.